Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hanna

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Neurourology and Urodynamics|May 20, 2014
Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013Lori A Birder, Karl-Erik Andersson, Anthony J Kanai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CTClaude Nahmias, Wahid T Hanna, Lindi M Wahl, et al.
The Journal of Endocrinology|May 16, 2014
Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cellsAnn T Hanna-Mitchell, Amanda Wolf-Johnston, James R Roppolo, et al.
American Journal of Human Genetics|April 1, 1991
Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr)M C Iannuzzi, N Hidaka, M Boehnke, et al.
The British Journal of Surgery|June 5, 2015
Systematic review of intervention design and delivery in pragmatic and explanatory surgical randomized clinical trialsN S Blencowe, A P Boddy, A Harris, et al.
Environmental Science and Pollution Research International|July 5, 2018
Correction to: Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposureDiaa A Hameed, Heba A Yassa, Michael N Agban, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|May 12, 2001
The Potential of F-18-FDG PET in Breast Cancer. Detection of Primary Lesions, Axillary Lymph Node Metastases, or Distant MetastasesK F. Hubner, G T. Smith, J A. Thie, et al.
British Journal of Haematology|July 22, 2014
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphomaMichael Craig, Wahid T Hanna, Fernando Cabanillas, et al.
Thrombosis and Haemostasis|February 1, 1994
The use of intermediate and high purity factor VIII products in the treatment of von Willebrand diseaseW T Hanna, R D Bona, C E Zimmerman, et al.
The Biochemical Journal|April 27, 2004
Phosphorylation of septin 3 on Ser-91 by cGMP-dependent protein kinase-I in nerve terminalsJing Xue, Peter J Milburn, Bernadette T Hanna, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Neurourology and Urodynamics|May 20, 2014
Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013Lori A Birder, Karl-Erik Andersson, Anthony J Kanai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2007
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CTClaude Nahmias, Wahid T Hanna, Lindi M Wahl, et al.
The Journal of Endocrinology|May 16, 2014
Corticotropin-releasing factor family peptide signaling in feline bladder urothelial cellsAnn T Hanna-Mitchell, Amanda Wolf-Johnston, James R Roppolo, et al.
American Journal of Human Genetics|April 1, 1991
Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr)M C Iannuzzi, N Hidaka, M Boehnke, et al.
The British Journal of Surgery|June 5, 2015
Systematic review of intervention design and delivery in pragmatic and explanatory surgical randomized clinical trialsN S Blencowe, A P Boddy, A Harris, et al.
Environmental Science and Pollution Research International|July 5, 2018
Correction to: Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposureDiaa A Hameed, Heba A Yassa, Michael N Agban, et al.
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|May 12, 2001
The Potential of F-18-FDG PET in Breast Cancer. Detection of Primary Lesions, Axillary Lymph Node Metastases, or Distant MetastasesK F. Hubner, G T. Smith, J A. Thie, et al.
British Journal of Haematology|July 22, 2014
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphomaMichael Craig, Wahid T Hanna, Fernando Cabanillas, et al.
Thrombosis and Haemostasis|February 1, 1994
The use of intermediate and high purity factor VIII products in the treatment of von Willebrand diseaseW T Hanna, R D Bona, C E Zimmerman, et al.
The Biochemical Journal|April 27, 2004
Phosphorylation of septin 3 on Ser-91 by cGMP-dependent protein kinase-I in nerve terminalsJing Xue, Peter J Milburn, Bernadette T Hanna, et al.
Pageof 8